Literature DB >> 8421365

Influence of diagnostic criteria on the incidence of gestational diabetes and perinatal morbidity.

M S Magee1, C E Walden, T J Benedetti, R H Knopp.   

Abstract

OBJECTIVE: To determine the incidence of gestational diabetes and its associated maternal and infant morbidity by two sets of 3-hour glucose tolerance test criteria, those recommended by the National Diabetes Data Group or the lower, modified criteria of Carpenter and Coustan.
DESIGN: Prospective, observational outcome cohort study.
SETTING: Prepaid health maintenance organization.
SUBJECTS: A total of 2019 pregnant women preregistered in a health maintenance organization were screened for a plasma glucose of 7.77 mmol/L (140 mg/dL) or greater, 1 hour after ingestion of a 50-g glucose drink administered after an overnight fast. Positive subjects received a 3-hour glucose tolerance test interpreted by the two criteria. Data are presented for 521 randomly selected negative screenees; 264 positive screen, negative glucose tolerance test subjects; and 101 subjects with gestational diabetes mellitus. OUTCOME MEASURES: Maternal risk factors for diabetes, infant birth weight corrected for gestational age (birth-weight ratio), umbilical cord serum insulin levels, and 33 maternal and infant perinatal morbidities assessed from chart review.
RESULTS: Gestational diabetes incidence was 5.0% overall based on the modified criteria and 3.2% by the recommended criteria. Maternal age and family history of diabetes were higher in both modified and recommended groups. Birthweight ratio was 1.05 in negative screenees, 1.09 in gestational diabetes overall (P < .05 when only diet-treated subjects were considered), and 1.11 in modified and 1.08 in recommended criteria groups. Cord serum insulin levels in infants of gestational diabetic mothers by both criteria were 40% above those of negative screenees (P < .001). The average percentage incidence of 33 possible perinatal morbidities was 41% higher in gestational diabetic pregnancies by the modified criteria. The cumulative number of morbidities was higher in both modified and recommended criteria groups (P < .01 in both instances). In contrast, subjects having a positive glucose screening test but a negative glucose tolerance test by modified criteria had none of the characteristics of gestational diabetes with the single exception of greater age.
CONCLUSIONS: Fifty percent more cases of gestational diabetes were identified using the more inclusive, modified criteria. These cases had as much excess in maternal diabetes risk factors, infant macrosomia, and cord hyperinsulinemia and nearly as much increase in perinatal morbidity as subjects diagnosed by the recommended criteria. The incidence and perinatal impact of gestational diabetes may be greater than previously appreciated. The modified criteria deserve wider verification and use.

Entities:  

Mesh:

Year:  1993        PMID: 8421365

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  27 in total

Review 1.  Gestational diabetes mellitus.

Authors:  Thomas A Buchanan; Anny H Xiang
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

Review 2.  Type 2 diabetes after gestational diabetes: The influence of changing diagnostic criteria.

Authors:  Eoin Noctor; Fidelma P Dunne
Journal:  World J Diabetes       Date:  2015-03-15

3.  Comparison of the criteria forgestational diabetes mellitus by NDDG and Carpenter and Coustan, and the outcomes of pregnancy.

Authors:  A Gokcel; T Bagis; E B Killicadag; E Tarim; N Guvener
Journal:  J Endocrinol Invest       Date:  2002-04       Impact factor: 4.256

4.  Using fasting plasma glucose concentrations to screen for gestational diabetes mellitus: prospective population based study.

Authors:  D Perucchini; U Fischer; G A Spinas; R Huch; A Huch; R Lehmann
Journal:  BMJ       Date:  1999-09-25

5.  Feasibility and efficacy of a physical activity intervention among pregnant women: the behaviors affecting baby and you (B.A.B.Y.) study.

Authors:  Lisa Chasan-Taber; Marushka Silveira; Bess H Marcus; Barry Braun; Edward Stanek; Glenn Markenson
Journal:  J Phys Act Health       Date:  2011-09

6.  Potential impact of American Diabetes Association (2000) criteria for diagnosis of gestational diabetes mellitus in Spain.

Authors:  W Ricart; J López; J Mozas; A Pericot; M A Sancho; N González; M Balsells; R Luna; A Cortázar; P Navarro; O Ramírez; B Flández; L F Pallardo; A Hernández; J Ampudia; J M Fernández-Real; R Corcoy
Journal:  Diabetologia       Date:  2005-05-12       Impact factor: 10.122

7.  The discovery of novel predictive biomarkers and early-stage pathophysiology for the transition from gestational diabetes to type 2 diabetes.

Authors:  Saifur R Khan; Haneesha Mohan; Ying Liu; Battsetseg Batchuluun; Himaben Gohil; Dana Al Rijjal; Yousef Manialawy; Brian J Cox; Erica P Gunderson; Michael B Wheeler
Journal:  Diabetologia       Date:  2019-01-15       Impact factor: 10.122

8.  A randomized controlled trial of prenatal physical activity to prevent gestational diabetes: design and methods.

Authors:  Lisa Chasan-Taber; Bess H Marcus; Edward Stanek; Joseph T Ciccolo; David X Marquez; Caren G Solomon; Glenn Markenson
Journal:  J Womens Health (Larchmt)       Date:  2009-06       Impact factor: 2.681

9.  Outcome of gestational diabetes mellitus from a tertiary referral center in South India: a case-control study.

Authors:  Mamta Bhat; K N Ramesha; Sankara P Sarma; Sangeetha Menon; S Ganesh Kumar
Journal:  J Obstet Gynaecol India       Date:  2012-08-17

Review 10.  Safety of influenza vaccination during pregnancy: a review of subsequent maternal obstetric events and findings from two recent cohort studies.

Authors:  Allison L Naleway; Stephanie A Irving; Michelle L Henninger; De-Kun Li; Pat Shifflett; Sarah Ball; Jennifer L Williams; Janet Cragan; Julianne Gee; Mark G Thompson
Journal:  Vaccine       Date:  2014-04-14       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.